About Dioxyfin

Transdermal therapy can support the healing of soft body tissue injuries, directly decrease inflammation and pain, act as an anti-oxidant to preserve tissue, and decrease the survival of hypoxic cancer cells. Scroll down for additional information, or read more details in our FAQ.

ABOUT DIOXYFIN

Transdermal Therapy

Laboratory studies in cells, animals and humans clearly demonstrate that carbon dioxide has many potential mechanisms for treating a variety of diseases.

Transdermal pharmaceutical carbon dioxide dramatically increases tissue blood flow and oxygenation. It also decreases concentration of HIF1 alpha and it directly decreases the main biological compound that regulates inflammation (NFkB). And, transdermal carbon dioxide has a powerful role in reducing the reactive oxygen species (ROS) thus ameliorating the ROS activity.

See How Vets Treat Their Patients.

Read some of our Vets Case Studies and sign up for updates!

Read Our Studies.

Check out white papers with addtional scientific literature.

Curious About the Treatment?

Check out our Treatment Checklist to see what is involved.

There is significant evidence based on the history of Sadie’s trauma, her treatments and the progression of the lameness, swelling and lesion that the transdermal carbon dioxide treatments had a direct and positive effect on improving degree of lameness and a likely positive effect by accelerating lesion healing and reducing inflammation.

Megan Mathias, DVM

The speed and quality of the healing process using carbon dioxide therapy on this case followed the outcomes of previous wound cases on which I have used the therapy. The outcomes on wound cases using transdermal carbon dioxide have been so consistent that it has become my primary modality for wound treatment and healing.

Anne-Marie Hancock, DVM

Proident quam duis quae ultricies natoque ut porttitor cumque, malesuada. suspendisse erat do curabitur hac nunc pede perferendis libero anim aenean luctus ullam, adipisci, explicabo.

Rock Smith Customer